Comparison of demographical features and chemical composition in patients with renal stones in a tertiary care center von Rammuthupura, K., Geeganage, K., De Silva, N., Fernando, M., Jayasena, S., Jayatissa, H., Sagara, A., Ruwanpathirana, N., Wijewardhana, M., Gunasekara, V., Lamahewage, A., Wijekoon, N., Abegunasekara, A., Silva, S., Goonesinghe, S.K.

Volltext

Highlights 2021: line of sight von Palmer, Joanna, Lahariya, Chandrakant, Jah, Hawanatu, Kongira, Fatoumata, Idris, Yahaya, Dodd, Savannah, Nasca, Melita M, Kent, James Clifford, Gonzalez Cárdenas, Hugo Rolando, Kumar, Alexander, Bellizzi, Saverio, Ohene-Frempong, Kwaku, Odetola, Folafoluwa, Beaumont, Nicolas, Senavirathna, Samantha Kumara, Geeganage, Saranga Dinusha, Abeysinghe, Padmakumari, Bawaskar, Himmatrao Saluba, Bawaskar, Promodini Himmatrao, Gan, Pearl, Hapugoda, Menaka, Sharma, Sanjib Kumar, Balasubramanya, KV, Pati, Manoj Kumar, N, Swaroop

Volltext

167 (PB155): Discovery of first-in-class precision antibody drug conjugates with a potent SMARCA2/4 dual degrader payload that safely achieve maximal and tumor specific degradation... von Carter, J., Agarwal, A., Sivakumar, M., Reichelderfer, A., Park, J., Osinubi, O., Holmes, R., Rager, J., Stahl, N., Cote, J., Crossan, A., Chen, C., Pawley, S., Wang, M., Geeganage, S., Lee, S., Combs, A., Scherle, P., Buesking, A., Ito, K.

Volltext

The protein kinase Cβ-selective inhibitor, enzastaurin (LY317615.HCI), suppresses signaling through the AKT pathway, induces apoptosis, and suppresses growth of human colon cancer... von GRAFF, Jeremy R, MCNULTY, Ann M, SAMS, Lillian, HUSS, Karen L, CAMPBELL, Robert M, IVERSEN, Philip W, NEUBAUER, Blake Lee, BROWN, Thomas J, MUSIB, Luna, GEEGANAGE, Sandaruwan, THORNTON, Donald, ROSS HANNA, Kimberly, KONICEK, Bruce W, LYNCH, Rebecca L, BAILEY, Spring N, BANKS, Crystal, CAPEN, Andrew, GOODE, Robin, LEWIS, Jason E

Volltext

A Phase I Study of an Anti-IDO1 Inhibitor (LY3381916) as Monotherapy and in Combination with an Anti-PD-L1 Antibody (LY3300054) in Patients with Advanced Cancer von Kotecki, N., O'Neil, B., Jalal, S., Massard, C., Wallin, J., Szpurka, A., Wang, D., Galvao, V. Regnier, Xia, M.S., Crowe, K., Geeganage, S., Doman, T., Gandhi, L., Xu, X., Bendell, J.

Volltext

P1.04-07 Pemetrexed Enhances Anti-Tumor Efficacy of PD-L1 blockade by Promoting Intra-Tumor Immune Response via Tumor and T Cell-Intrinsic Mechanisms von Schaer, D., Geeganage, S., Amaladas, N., Lu, Z.H., Rasmussen, E., Sonyi, A., Chin, D., Capen, A., Li, Y., Meyer, C., Jones, B., Huang, X., Luo, S., Carpenito, C., Roth, K., Nikolayev, A., Tan, B., Brahmachary, M., Chodavarapu, K., Dorsey, F., Manro, J., Doman, T., Donoho, G., Hall, G., Kalos, M., Novosiadly, R.

Volltext

Temperature-Dependent Formation of a Conjugate between Tris(hydroxymethyl)aminomethane Buffer and the Malondialdehyde−DNA Adduct Pyrimidopurinone von Niedernhofer, Laura J, Riley, Michael, Schnetz-Boutaud, Nathalie, Sanduwaran, Geeganage, Chaudhary, Ajai K, Reddy, G. Ramachandra, Marnett, Lawrence J

Volltext

A configurable multi-core processor for teaching parallel processing von Udugama, L. S. K., Geeganage, Janath, Kuruppuarachchi, W. V.

Volltext